BC Cancer Protocol Summary for DOXOrubicin – Ifosfamide - Mesna. For Use In Patients With Advanced Soft Tissue Sarcoma. Protocol Code. SAAI. Tumour Group.
SAAI Protocol
1 nov. 2019 BC Cancer Protocol Summary for 3-day DOXOrubicin – ifosfamide - mesna for use in Patients with Advanced Soft Tissue Sarcoma. Protocol Code.
SAAI Protocol
Mesna. 3g/m. 2. IV. Days 1 2 and 3 of cycle. Ifosfamide + Mesna Doxorubicin: Vesicant – follow trust / network extravasation policy
1 juin 1990 Four courses of ifosfamide with mesna given by intravenous infusions were combined with bolus doxorubicin in a phase I1 trial to treat ...
20 déc. 2016 Mesna is administered prior to the first dose of ifosfamide on Day. 1 and is continued throughout the chemotherapy up to 24 hrs after the ...
Mesna. Perfusion intraveineuse sur _____ heure(s) avec l'ifosfamide les jours ______. Puis en perfusion de 15 minutes ou par la bouche 4 heures et 8 heures
Ifosfamide Doxorubicin Fr ?
BC Cancer Protocol Summary for Etoposide Ifosfamide-Mesna. (SAIME) Alternating with vinCRIStine
SAALT W Protocol
Refer to DOXOrubicin ifosfamide
DOXOIFOS SA ST ?download=
with high-dose ifosfamide/mesna by continuous infusion in pre-treated with doxorubicin plus ifosfamide 6 months earlier.
5 avr. 2021 EPIC 3874: SARCOMA Soft tissue - AIM (DOXOrubicin + Ifosfamide +. Mesna) Q3W max 6 cycles. AIM (DOXOrubicin + Ifosfamide + Mesna).
Sarcoma (Soft Tissue) AIM (DOXOrubicin Ifosfamide Mesna)